SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-233321
Filing Date
2015-06-24
Accepted
2015-06-24 16:02:05
Documents
5
Period of Report
2015-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d949458d8k.htm 8-K 18103
2 EX-10.1 d949458dex101.htm EX-10.1 8757
3 EX-99.1 d949458dex991.htm EX-99.1 10420
4 EX-99.2 d949458dex992.htm EX-99.2 11377
5 GRAPHIC g949458g88c93.jpg GRAPHIC 3726
  Complete submission text file 0001193125-15-233321.txt   55419
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 15949244
SIC: 2834 Pharmaceutical Preparations